Lundin A - Search Results

1

A Huntington disease-like neurodegenerative disorder maps to chromosome 20p.

Xiang F, Almqvist EW, Huq M, Lundin A, Hayden MR, Edström L, Anvret M, Zhang Z. Xiang F, et al. Among authors: lundin a. Am J Hum Genet. 1998 Nov;63(5):1431-8. doi: 10.1086/302093. Am J Hum Genet. 1998. PMID: 9792871 Free PMC article.

2

Reactions to predictive testing in Huntington disease: case reports of coping with a new genetic status.

Wahlin TB, Lundin A, Bäckman L, Almqvist E, Haegermark A, Winblad B, Anvret M. Wahlin TB, et al. Among authors: lundin a. Am J Med Genet. 1997 Dec 19;73(3):356-65. doi: 10.1002/(sici)1096-8628(19971219)73:3<356::aid-ajmg24>3.0.co;2-h. Am J Med Genet. 1997. PMID: 9415699

3

Larger CAG expansions in skeletal muscle compared with lymphocytes in Kennedy disease but not in Huntington disease.

Ansved T, Lundin A, Anvret M. Ansved T, et al. Among authors: lundin a. Neurology. 1998 Nov;51(5):1442-4. doi: 10.1212/wnl.51.5.1442. Neurology. 1998. PMID: 9818876

4

Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease.

Sedvall G, Karlsson P, Lundin A, Anvret M, Suhara T, Halldin C, Farde L. Sedvall G, et al. Among authors: lundin a. Eur Arch Psychiatry Clin Neurosci. 1994;243(5):249-55. doi: 10.1007/BF02191583. Eur Arch Psychiatry Clin Neurosci. 1994. PMID: 8172940

5

High suicidal ideation in persons testing for Huntington's disease.

Robins Wahlin TB, Bäckman L, Lundin A, Haegermark A, Winblad B, Anvret M. Robins Wahlin TB, et al. Among authors: lundin a. Acta Neurol Scand. 2000 Sep;102(3):150-61. doi: 10.1034/j.1600-0404.2000.102003150.x. Acta Neurol Scand. 2000. PMID: 10987374

6

PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.

Ginovart N, Lundin A, Farde L, Halldin C, Bäckman L, Swahn CG, Pauli S, Sedvall G. Ginovart N, et al. Among authors: lundin a. Brain. 1997 Mar;120 ( Pt 3):503-14. doi: 10.1093/brain/120.3.503. Brain. 1997. PMID: 9126061

7

Early cognitive deficits in Swedish gene carriers of Huntington's disease.

Robins Wahlin TB, Lundin A, Dear K. Robins Wahlin TB, et al. Among authors: lundin a. Neuropsychology. 2007 Jan;21(1):31-44. doi: 10.1037/0894-4105.21.1.31. Neuropsychology. 2007. PMID: 17201528

8

Olfactory functions in asymptomatic carriers of the Huntington disease mutation.

Larsson M, Lundin A, Robins Wahlin TB. Larsson M, et al. Among authors: lundin a. J Clin Exp Neuropsychol. 2006 Nov;28(8):1373-80. doi: 10.1080/13803390500473746. J Clin Exp Neuropsychol. 2006. PMID: 17050264

9

Comorbidities of obsessive and compulsive symptoms in Huntington's disease.

Anderson KE, Gehl CR, Marder KS, Beglinger LJ, Paulsen JS; Huntington's Study Group. Anderson KE, et al. J Nerv Ment Dis. 2010 May;198(5):334-8. doi: 10.1097/NMD.0b013e3181da852a. J Nerv Ment Dis. 2010. PMID: 20458194 Free PMC article.

10

Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes.

Bäckman L, Robins-Wahlin TB, Lundin A, Ginovart N, Farde L. Bäckman L, et al. Among authors: lundin a. Brain. 1997 Dec;120 ( Pt 12):2207-17. doi: 10.1093/brain/120.12.2207. Brain. 1997. PMID: 9448576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

393 results

Search Page

Filters